Looking at The Inside

Yesterday’s update showed biotech sector IBB, in a bearish divergence.
The list of components can be found here.
For today, we’ll look at some of the technical characteristics pointing to potential for a downside reversal (not advice, not a recommendation).
Biotech IBB, Weekly

A wedge typically occurs at the end of a move, whether up or down (not advice, not a recommendation).
Price action has met the ‘measured move’ target and even gone slightly above.
The potential bearish MACD is shown.
If the coming week is flat or down, we’ll (likely) have a tick lower in MACD, completing the divergence signal.
Fo the next update, we’ll discuss a much larger ‘terminating’ wedge and more.
Stay Tuned
Charts by StockCharts, TC2000
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279
Pingback: Biotech … Downside Reversal? « The Danger Point®